Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis

BACKGROUND: The albumin-bilirubin (ALBI) score is an index of liver function recently developed to assess prognosis in patients with hepatocellular carcinoma (HCC). It can detect small changes in liver dysfunction and has been successfully applied to the prediction of survival in patients with non-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Navadurong, Huttakan, Thanapirom, Kessarin, Wejnaruemarn, Salisa, Prasoppokakorn, Thaninee, Chaiteerakij, Roongruedee, Komolmit, Piyawat, Treeprasertsuk, Sombat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494764/
https://www.ncbi.nlm.nih.gov/pubmed/37701131
http://dx.doi.org/10.3748/wjg.v29.i32.4873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494764/
https://www.ncbi.nlm.nih.gov/pubmed/37701131
http://dx.doi.org/10.3748/wjg.v29.i32.4873

Ejemplares similares